SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-186066
Filing Date
2019-06-28
Accepted
2019-06-28 16:26:33
Documents
5
Period of Report
2019-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d741496d8k.htm 8-K 21464
2 EX-1.1 d741496dex11.htm EX-1.1 209151
3 EX-5.1 d741496dex51.htm EX-5.1 9211
4 GRAPHIC g741496g0627125613378.jpg GRAPHIC 2370
5 GRAPHIC g741496img01.jpg GRAPHIC 20886
  Complete submission text file 0001193125-19-186066.txt   273474
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 19929749
SIC: 2834 Pharmaceutical Preparations